Who Are More Likely to Develop Central Serous Chorioretinopathy (CSCR)?

Key Takeaways

• CSCR tends to affect younger to middle-aged adults, especially men. It is most commonly seen in males aged roughly 30–50 years.

• Stress, corticosteroid use, and systemic conditions are major contributors. Elevated cortisol levels, steroid medications, hypertension, and sleep apnea significantly increase susceptibility.

• This disease has been found to have higher prevalence in men than women. Several population studies report a male-to-female ratio of roughly 6:1.

• Understanding risk factors encourages early monitoring and timely care. Individuals who fall into multiple risk categories should promptly seek evaluation if they experience blurred or distorted central vision.

Central Serous Chorioretinopathy (CSCR) is a retinal disorder involving fluid accumulation beneath the macula, the central area of the retina responsible for sharp, detailed vision [1]. This fluid collects due to leakage from the retinal pigment epithelium (RPE), causing the macula to elevate slightly. 

As a result, patients may experience visual distortion, blurriness, or a darkened central spot. While symptoms sometimes resolve naturally, certain patients are more likely to develop CSCR and more prone to recurrences, making early evaluation and appropriate central serous chorioretinopathy treatment essential [2].

Understanding the Basics of CSCR

CSCR is often associated with stress and systemic factors that elevate cortisol levels. The condition causes a localized detachment of the neurosensory retina when fluid accumulates under the macula. 

In many cases, symptoms improve spontaneously within weeks or months. However, persistent or recurrent CSCR can damage the retina over time and may require central serous chorioretinopathy treatment to prevent sustained vision impairment.

Although commonly diagnosed in younger adults, CSCR can also affect older individuals and women. The condition usually presents without pain, but the visual disturbances can significantly impact reading, driving, and tasks that require central vision.

Higher Risk in Men Between Ages 20 to 50

One of the strongest risk factors for CSCR is gender, with men aged 30 to 50 disproportionately affected [3]. Hormonal differences, particularly those related to cortisol regulation, may contribute to this disparity. Occupational stressors, competitive environments, and physically demanding work may place men in this age group at increased risk.

While CSCR can occur in women, the difference in risk remains notable across multiple studies. This demographic pattern highlights the importance of routine eye examinations for men experiencing visual symptoms, especially those with chronic stress or high-pressure lifestyles.

Individuals with High Stress or Anxiety Levels

Chronic stress is one of the most significant contributors to CSCR because elevated cortisol can affect both the retinal pigment epithelium and the choroidal blood vessels beneath the retina [4]. When cortisol remains consistently high, fluid regulation in the eye becomes disrupted, making leakage more likely.

People working long hours, managing demanding careers, or facing significant emotional strain may face heightened risk. Stress does not need to be work-related to have an impact; relationship conflicts, financial difficulties, and ongoing anxiety can also contribute. 

Managing stress through counseling, meditation, breathing exercises, or physical activity may help reduce the likelihood of recurrence and improve response to central serous chorioretinopathy treatment.

Users of Corticosteroid Medications

Corticosteroids are widely used to manage inflammatory, respiratory, allergic, and autoimmune conditions. Unfortunately, prolonged or high-dose steroid use—regardless of the route—raises the risk of CSCR. This includes:

• Oral corticosteroids

• Inhaled steroids for asthma

• Nasal sprays for allergies

• Topical creams or ointments

• Steroid injections

Even frequent use of over-the-counter topical steroids may increase risk. For individuals who develop CSCR while taking steroids, healthcare providers may recommend adjusting or discontinuing the medication in addition to considering central serous chorioretinopathy treatment.

Individuals with Type A Personality Traits

People with Type A personality characteristics often experience elevated cortisol and adrenaline levels due to competitive tendencies, perfectionism, and fast-paced routines [5]. These individuals may unintentionally overlook early symptoms or postpone eye assessments, increasing the risk of prolonged fluid accumulation in the retina. Awareness and timely eye care are particularly important for those with Type A tendencies, especially when combined with other risk factors such as stress or steroid use.

People with Hypertension or Cardiovascular Issues

Systemic health conditions significantly influence CSCR risk. Hypertension, sleep apnea, and metabolic or cardiovascular disorders may affect choroidal blood flow, increasing pressure within the layers beneath the retina. This heightened pressure can make fluid leakage more likely.

Managing blood pressure, improving sleep quality, and addressing underlying cardiovascular issues can help lower the chances of recurrence and support the effectiveness of central serous chorioretinopathy treatment.

Pregnant Women and Hormonal Influences

Although CSCR is rare in pregnancy, hormonal fluctuations and naturally elevated cortisol levels can make pregnant women more susceptible. In many cases, CSCR that develops during pregnancy resolves after delivery. Nevertheless, regular monitoring ensures that visual function remains stable and that the condition does not progress.

Frequent Use of Stimulants

Caffeine, nicotine, and energy drinks increase cortisol and adrenaline, which may influence the choroidal circulation. While occasional stimulant use is usually safe, frequent or excessive intake may heighten risk, particularly when combined with stress or other contributing factors. Smoking and vaping have additional negative effects on retinal and vascular health.

Individuals with Previous CSCR Episodes

Patients who have experienced CSCR once are at higher risk of recurrence, highlighting the need for close monitoring and timely treatment [6]. Identifying symptom patterns early—such as sudden blurring or central visual distortion—allows for prompt evaluation and timely CSCR treatment before damage becomes permanent.

The following table summarizes the key groups and risk factors associated with a higher likelihood of developing CSCR.

Risk Factor / Group	Description / Notes
Men aged 30–50	Hormonal differences and lifestyle factors contribute to higher susceptibility.
High stress or anxiety	Elevated cortisol disrupts retinal fluid regulation; includes occupational, emotional, or relationship stress.
Corticosteroid users	Oral, inhaled, topical, or injected steroids increase risk; even frequent OTC steroid use may contribute.
Type A personality	Competitive, perfectionist tendencies elevate cortisol and may delay symptom recognition.
Hypertension / cardiovascular issues	Systemic conditions affect choroidal blood flow, increasing fluid leakage risk.
Pregnancy	Hormonal fluctuations and higher cortisol levels may predispose to CSCR; usually resolves postpartum.
Frequent stimulant use	Caffeine, nicotine, and energy drinks may increase cortisol and choroidal stress.
Previous CSCR episodes	History of CSCR increases likelihood of recurrence; early monitoring is essential.

When Treatment Becomes Necessary

Although many cases resolve spontaneously, persistent, recurrent, or severe CSCR may require intervention. Common central serous chorioretinopathy care options include:

• Photodynamic therapy, which targets abnormal choroidal circulation

• Thermal laser therapy for specific leakage points

• Medications that reduce choroidal vascular permeability or modulate cortisol pathways

Ophthalmologists may also advise lifestyle adjustments to improve outcomes, such as reducing stress, avoiding unnecessary steroid use, and managing systemic health conditions.

Taking Proactive Steps to Protect Vision

Awareness of risk factors enables individuals to take early steps to safeguard their vision. Anyone who falls into a higher-risk group should monitor for symptoms such as blurry central vision, distortion of straight lines, or difficulty focusing.

Prompt evaluation leads to earlier intervention, whether observation or central serous chorioretinopathy management is needed. Although CSCR typically does not cause permanent vision loss when detected early, repeated episodes can damage the retina over time. Understanding personal risk empowers individuals to protect their eyesight, maintain ocular health, and reduce the likelihood of long-term complications.

References

1. National Eye Institute. (2023). Central serous chorioretinopathy. U.S. Department of Health and Human Services. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/central-serous-chorioretinopathy

2. Liew, G., Quin, G., Gillies, M., & Fraser-Bell, S. (2013). Central serous chorioretinopathy: A review of epidemiology and pathophysiology. Clinical & Experimental Ophthalmology, 41(2), 201–214. https://doi.org/10.1111/ceo.12033

3. van Dijk, E. H., Fauser, S., Breukink, M. B., Blanco-Garavito, R., van Rijssen, T. J., & Keunen, J. E. E. (2019). Risk factors and clinical presentation of central serous chorioretinopathy in men. Ophthalmology Retina, 3(6), 504–512. https://doi.org/10.1016/j.oret.2019.01.008

4. Wang, M., Munch, I. C., Hasler, P. W., Prünte, C., Larsen, M. (2008). Central serous chorioretinopathy. Acta Ophthalmologica, 86(2), 126–145. https://doi.org/10.1111/j.1600-0420.2007.00970.x

5. Chrapek, M., Kłos, P., & Stankiewicz, A. (2020). Psychosocial factors in central serous chorioretinopathy. Medical Hypothesis, Discovery & Innovation Ophthalmology Journal, 9(1), 26–31. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002393/

6. Daruich, A., Matet, A., Behar-Cohen, F. (2015). Central serous chorioretinopathy: Recurrence and chronicity. International Ophthalmology, 35(6), 871–888. https://doi.org/10.1007/s10792-015-0037-4